Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	DOUBEK Michael BRYCHTOVÁ Yvona PANOVSKÁ Anna TRIZULJAK J. ŠEBEJOVÁ Ludmila STEHLÍKOVÁ Olga CHOVANCOVÁ Jana MALČÍKOVÁ Jitka ŠMARDOVÁ Jana PLEVOVÁ Karla VOLFOVÁ Pavlína TRBUŠEK Martin MRÁZ Marek MAJERČÁKOVÁ Denisa OBRTLÍKOVÁ Petra KARBAN Josef SMOLEJ Lukáš LINDTNEROVÁ Michaela OLTOVÁ Alexandra JELÍNKOVÁ Eva POSPÍŠILOVÁ Šárka MAYER Jiří
Year of publication	2013
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation